Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Oct 6;6(2):E298-310.
doi: 10.1208/pt060240.

Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review

Affiliations
Review

Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review

Rajiv Kumar et al. AAPS PharmSciTech. .

Abstract

The purpose of this review is to give an insight into the considerable potential of lecithin organogels (LOs) in the applications meant for topical drug delivery. LOs are clear, thermodynamically stable, viscoelastic, and biocompatible jelly-like phases, chiefly composed of hydrated phospholipids and appropriate organic liquid. These systems are currently of interest to the pharmaceutical scientist because of their structural and functional benefits. Several therapeutic agents have been formulated as LOs for their facilitated transport through topical route (for dermal or transdermal effect), with some very encouraging results. The improved topical drug delivery has mainly been attributed to the biphasic drug solubility, the desired drug partitioning, and the modification of skin barrier function by the organogel components. Being thermodynamically stable, LOs are prepared by spontaneous emulsification and therefore possess prolonged shelf life. The utility of this novel matrix as a topical vehicle has further increased owing to its very low skin irritancy potential. Varied aspects of LOs viz formation, composition, phase behavior, and characterization have been elaborated, including a general discussion on the developmental background. Besides a comprehensive update on the topical applications of lecithin organogels, the review also includes a detailed account on the mechanistics of organogelling.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Barr M. Percutaneous absorption. J Pharm Sci. 1962;61:395–409. doi: 10.1002/jps.2600510502. - DOI
    1. Hadgraft J, Guy RH. Transdermal Drug Delivery: Development Issues and Research Initiatives. New York, NY: Marcel Dekker; 1989.
    1. Asmussen B. Transdermal therapeutic systems—actual state and future developments. Methods Find Exp Clin Pharmacol. 1991;13:343–351. - PubMed
    1. Hadgraft J. Recent developments in topical and transdermal delivery. Eur J Drug Metab Pharmacokinet. 1996;21:165–173. doi: 10.1007/BF03190266. - DOI - PubMed
    1. Cevc G. Drug delivery across the skin. Expert Opin Investig Drugs. 1997;6:1887–1937. doi: 10.1517/13543784.6.12.1887. - DOI - PubMed

Publication types

LinkOut - more resources